HEVS:PA:PA-HSBC MSCI Emerging Markets Value ESG UCITS ETF USD (Acc) EUR (EUR)

ETF | Others |

Last Closing

USD 13.6446

Change

+0.09 (+0.64)%

Market Cap

N/A

Volume

0.01M

Analyst Target

N/A
Analyst Rating

N/A

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-12-24 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
JPX4:PA Amundi Index Solutions - Amund..

+0.20 (+0.44%)

USD 61.38B
SPY5:PA SPDR® S&P 500 UCITS ETF EUR

+4.40 (+0.77%)

USD 13.43B
WRD:PA HSBC MSCI World UCITS ETF

+0.27 (+0.76%)

USD 11.05B
SP5C:PA Lyxor S&P 500 UCITS ETF - C-EU..

+3.57 (+0.88%)

USD 9.62B
MEUD:PA Amundi Stoxx Europe 600 UCITS ..

-0.25 (-0.11%)

USD 8.55B
EQQQ:PA Invesco EQQQ NASDAQ-100 UCITS ..

+4.50 (+0.89%)

USD 8.53B
HHH:PA HSBC S&P 500 UCITS ETF

+0.46 (+0.79%)

USD 7.68B
WLD:PA Lyxor UCITS MSCI World D-EUR

+3.17 (+0.89%)

USD 7.63B
LCWD:PA Multi Units Luxembourg - Lyxor..

+0.17 (+0.88%)

USD 6.83B
S500:PA Amundi S&P 500 ESG UCITS ETF A..

+1.58 (+0.97%)

USD 5.48B

ETFs Containing HEVS:PA

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 19.05% 69% C- 78% C+
Dividend Return N/A N/A N/A N/A N/A
Total Return 19.05% 69% C- 77% C+
Trailing 12 Months  
Capital Gain 21.95% 73% C 80% B-
Dividend Return N/A N/A N/A N/A N/A
Total Return 21.95% 72% C 79% B-
Trailing 5 Years  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Average Annual (5 Year Horizon)  
Capital Gain 6.56% 46% F 54% F
Dividend Return 6.56% 45% F 52% F
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 9.91% 68% D+ 81% B-
Risk Adjusted Return 66.21% 50% F 71% C-
Market Capitalization N/A N/A N/A N/A N/A

Annual Financials (EUR)

Quarterly Financials (EUR)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:

There is nothing we particularly like

What to not like:
Poor risk adjusted returns

This company is delivering below median risk adjusted returns in its peers. Even if it is outperforming on returns , the returns are unpredictable. Proceed with caution.

Below median dividend returns

The company’s average income yield over the past 5 years has been low compared to its peers. However, it is not a problem if you are not looking for income.